| KEGG Pathway | Cytokine-cytokine receptor interaction, Pathways of neurodegeneration, Influenza A, Rheumatoid arthritis, Human cytomegalovirus infection, Tuberculosis, Fluid shear stress and atherosclerosis, Salmonella infection, Lipid and atherosclerosis, Viral protein interaction with cytokine and cytokine receptor, MAPK signaling pathway, Proteoglycans in cancer, Coronavirus disease, Human papillomavirus infection, Hematopoietic cell lineage, Amoebiasis, Shigellosis, Toxoplasmosis, TGF-beta signaling pathway, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Herpes simplex virus 1 infection, Amyotrophic lateral sclerosis, Inflammatory bowel disease, Malaria, NF-kappa B signaling pathway, Leishmaniasis, IL-17 signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Hepatitis C, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Hepatitis B, Alzheimer disease, Hypertrophic cardiomyopathy, Human immunodeficiency virus 1 infection, Chagas disease, Non-alcoholic fatty liver disease, Yersinia infection, Pathogenic Escherichia coli infection, African trypanosomiasis, Prion disease, Necroptosis, Alcoholic liver disease, TNF signaling pathway, Legionellosis, Graft-versus-host disease, Dilated cardiomyopathy, Type I diabetes mellitus, Pertussis, Adipocytokine signaling pathway, Asthma, Insulin resistance, Allograft rejection, Osteoclast differentiation, Systemic lupus erythematosus, Sphingolipid signaling pathway, Antigen processing and presentation, C-type lectin receptor signaling pathway, Apoptosis, Antifolate resistance, RIG-I-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Fc epsilon RI signaling pathway, mTOR signaling pathway, T cell receptor signaling pathway, Type II diabetes mellitus |
